ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 162

Depression Versus Frustration

Robert S. Katz1 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: depression and fibromyalgia

Session Information

Date: Sunday, November 5, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with fibromyalgia may feel depressed. But is it a clinical depression, suggesting the need for SSRI, SNRI, or other medication, or is it frustration related to the presence of the symptoms of the disease?

 

Methods: 115 fibromyalgia syndrome (FMS) patients, meeting the 2010 ACR criteria for the diagnosis, completed a questionnaire in a rheumatology office practice asking whether they were depressed and also whether they felt frustrated. The 62 FMS patients who responded yes to having depression also filled out a Patient Health Questionnaire-9 (PHQ-9) for depression. The PHQ-9 asked the following questions: little interest in doing things; feeling down/depressed; trouble with sleep; feeling tired/low energy; poor appetite; feeling bad about oneself; poor concentration; moving and speaking slowly or excessively fidgety; and thoughts of hurting oneself. Patients were asked to rate these questions based on how they felt over the last two weeks, as follows: 0 for not at all, 1 for several days, 2 for "more than half the days and 3 for nearly every day. A score of 5-9 minimal symptoms, 10-14 minor depression, 15-19 major depression, moderate; and >20 major depression, severe.

 

Results: 96 FMS patients responded yes to the question “are you frustrated?”  When asked, “Are you depressed?”, 62 FMS patients answered yes. Scores of the PHQ-9 in the 62 FMS patients feeling depressed were as follows:  12 (19.3%) that scored in the 5-9 range (“minimal symptoms”), 18 (29.2%) that scored in the 10-14 range (“minor depression”), 22 (35.4%) that scored in the 15-19 range (Major depression, moderate), and 10 (16.1%) that scored in the >20 range (Major depression, severe).

Conclusion: Of 115 patients with fibromyalgia, 62 reported depression. Using the PHQ-9 depression questionnaire 22 of these patients had a moderate major depression and 10 severe major depression. The great majority of patients with fibromyalgia express frustration but don’t meet the criteria for depression, based on the PHQ-9 questionnaire. Psychotherapy, including ventilation of the patient’s symptoms in the rheumatologist’s office, and continued in a psychologist’s or psychiatrist’s office, can be important. Separating depression, with the possibility of prescribing antidepressant medications, and frustration can be clinically and therapeutically important.


Disclosure: R. S. Katz, None; J. L. Polyak, None.

To cite this abstract in AMA style:

Katz RS, Polyak JL. Depression Versus Frustration [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/depression-versus-frustration/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/depression-versus-frustration/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology